Photo of William Calhoun

View Scopus Profile

William Calhoun, MD

Vice Chair, Research

  • 11503 Citations
  • 53 h-Index
1977 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Allergy/Immunology, Fellowship, University of Wisconsin-Madison

… → 1992

Pulmonary, Fellowship, University of Vermont, Burlington

… → 1985

Medicine, Residency, Pennsylvania State University, Hershey

… → 1982

Medicine, MD, Pennsylvania State University, Hershey

… → 1979

Chemistry, BS, University of Delaware

… → 1975

Research interests

  • Asthma

Fingerprint Dive into the research topics where William Calhoun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammatio

Calhoun, W.

Sanofi US Services Inc

11/7/19 → 11/6/22

Project: Other project

Study D3250C00059: A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK)

Calhoun, W.

AstraZeneca LP

8/19/19 → 8/18/21

Project: Other project

A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older

Calhoun, W.

Bond Avillion 2 Development LP

7/22/19 → 7/21/21

Project: Other project

A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma control

Calhoun, W.

AstraZeneca LP

2/6/19 → 2/5/21

Project: Other project

A Multicenter, Open-label, Phase 3b Efficacy and Safety Study of Benralizumab 30 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Patients with Severe Eosinophilic Asthma on High-Dose Inhaled Corticosteroid plus Long-acting ?2 Ag

Calhoun, W.

AstraZeneca LP

10/19/18 → 10/18/20

Project: Other project

Research Output

Management of Acute Asthma in Adults in 2020

Zaidan, M. F., Ameredes, B. T. & Calhoun, W. J., Feb 11 2020, In : JAMA - Journal of the American Medical Association. 323, 6, p. 563-564 2 p.

Research output: Contribution to journal › Short survey

1 Scopus citations

Outpatient Management of Chronic Asthma in 2020

Tripple, J. W., Ameredes, B. T. & Calhoun, W. J., Feb 11 2020, In : JAMA - Journal of the American Medical Association. 323, 6, p. 561-562 2 p.

Research output: Contribution to journal › Short survey

1 Scopus citations

Chronic Respiratory Disease and Cognitive Impairment in Older Mexican Adults

Veeranki, S., Downer, B., Jupiter, D., Kuo, Y. F., Raji, M., Calhoun, W. & Wong, R., Nov 1 2019, In : Neurology India. 67, 6, p. 1539-1542 4 p.

Research output: Contribution to journal › Article

    • Ethanol Exposure Impairs AMPK Signaling and Phagocytosis in Human Alveolar Macrophages: Role of Ethanol Metabolism

    Kaphalia, L., Prathivadibhayankaram, M., Kakumanu, R. D., Kaphalia, B. & Calhoun, W., Jan 1 2019, In : Alcoholism: Clinical and Experimental Research.

    Research output: Contribution to journal › Article

    • Forced Oscillometry: A New Tool for Assessing Airway Function—Is It Ready for Prime Time?

    Ram, J., Pineda-Cely, J. & Calhoun, W. J., Nov 1 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 8, p. 2861-2862 2 p.

    Research output: Contribution to journal › Editorial